When did Nurix Therapeutics, Inc. report Q4 2024 earnings?

Nurix Therapeutics, Inc. (NRIX) reported Q4 2024 earnings on January 28, 2025 before market open.

What were Nurix Therapeutics, Inc.'s Q4 2024 revenue and EPS?

Nurix Therapeutics, Inc. reported revenue of $13.3M and diluted EPS of $-0.75 for Q4 2024.

Revenue missed the consensus estimate of $14.8M by $1.5M. EPS missed the consensus estimate of $-0.67 by $0.08.

You can read the 10-K periodic report (0001549595-25-000016) directly on SEC EDGAR. The filing index links above go to sec.gov.

Reported January 28, 2025 · Before market open

Revenue estimate$14.8M

EPS estimate-$0.67

Jul 9, 2026 (In 2 weeks)

Revenue estimate$15.3M

EPS estimate-$0.73

Q4 2024$13.3MMiss by $1.5M

Q4 2024-$0.75Miss by $0.08

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

When did Nurix Therapeutics, Inc. report Q4 2024 earnings?: Nurix Therapeutics, Inc. (NRIX) reported Q4 2024 earnings on January 28, 2025 before market open.
What were Nurix Therapeutics, Inc.'s Q4 2024 revenue and EPS?: Nurix Therapeutics, Inc. reported revenue of $13.3M and diluted EPS of $-0.75 for Q4 2024.
Did Nurix Therapeutics, Inc. beat estimates in Q4 2024?: Revenue missed the consensus estimate of $14.8M by $1.5M. EPS missed the consensus estimate of $-0.67 by $0.08.
Where can I find Nurix Therapeutics, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0001549595-25-000016) directly on SEC EDGAR. The filing index links above go to sec.gov.